Alan T. Savitz

425 total citations
11 papers, 237 citations indexed

About

Alan T. Savitz is a scholar working on Cognitive Neuroscience, Endocrine and Autonomic Systems and Experimental and Cognitive Psychology. According to data from OpenAlex, Alan T. Savitz has authored 11 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cognitive Neuroscience, 6 papers in Endocrine and Autonomic Systems and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in Alan T. Savitz's work include Sleep and Wakefulness Research (7 papers), Sleep and related disorders (5 papers) and Circadian rhythm and melatonin (5 papers). Alan T. Savitz is often cited by papers focused on Sleep and Wakefulness Research (7 papers), Sleep and related disorders (5 papers) and Circadian rhythm and melatonin (5 papers). Alan T. Savitz collaborates with scholars based in United States, Netherlands and Belgium. Alan T. Savitz's co-authors include Christopher J. Winrow, Anthony L. Gotter, John J. Renger, Steven V. Fox, Pamela L. Tannenbaum, Scott D. Kuduk, Jason M. Uslaner, Paul J. Coleman, Spencer J. Tye and Joanne Stevens and has published in prestigious journals such as Pain, Neuropsychopharmacology and SLEEP.

In The Last Decade

Alan T. Savitz

11 papers receiving 227 citations

Peers

Countries citing papers authored by Alan T. Savitz

Since Specialization

Citations

This map shows the geographic impact of Alan T. Savitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan T. Savitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan T. Savitz more than expected).

Fields of papers citing papers by Alan T. Savitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan T. Savitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan T. Savitz. The network helps show where Alan T. Savitz may publish in the future.

Co-authorship network of co-authors of Alan T. Savitz

This figure shows the co-authorship network connecting the top 25 collaborators of Alan T. Savitz. A scholar is included among the top collaborators of Alan T. Savitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan T. Savitz. Alan T. Savitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Analgesia and peripheral c-fiber modulation by selective Nav1.8 inhibition in rhesus 2024 ·Pain ·Joshua D. Vardigan, (unknown), (unknown), Chien-Jung Huang, Michelle K. Clements, Yuxing Li, Richard L. Kraus, Michael J. Breslin, Christopher J. Bungard, (unknown), (unknown), (unknown), M. E. Layton, Shawn J. Stachel, Henry S. Lange, Alan T. Savitz, Vincent P. Santarelli, Darrell A. Henze, Jason M. Uslaner	3
2	341 Acute effects of seltorexant, a selective orexin-2 antagonist (JNJ- 42847922), on driving after bedtime administration 2021 ·SLEEP ·(unknown), Rob Zuiker, Gabriël E. Jacobs, Iva Kezic, Alan T. Savitz, Peter van der Ark, Joop van Gerven	1
3	Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys 2016 ·SLEEP ·Pamela L. Tannenbaum, Spencer J. Tye, Joanne Stevens, Anthony L. Gotter, Steven V. Fox, Alan T. Savitz, Paul J. Coleman, Jason M. Uslaner, Scott D. Kuduk, Richard Hargreaves, Christopher J. Winrow, John J. Renger	41
4	Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties 2015 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk, (unknown), (unknown), Joseph G. Bruno, Mark H. Pausch, Julie A. O’Brien, Tamara D. Cabalu, Joanne Stevens, (unknown), Pamela L. Tannenbaum, Susan L. Garson, Alan T. Savitz, C. Meacham Harrell, Anthony L. Gotter, Christopher J. Winrow, John J. Renger, Paul J. Coleman	15
5	Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs 2014 ·Frontiers in Behavioral Neuroscience ·Pamela L. Tannenbaum, Joanne Stevens, (unknown), Alan T. Savitz, Susan L. Garson, Steven V. Fox, Paul J. Coleman, Scott D. Kuduk, Anthony L. Gotter, Michael J. Marino, Spencer J. Tye, Jason M. Uslaner, Christopher J. Winrow, John J. Renger	32
6	Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats 2013 ·Neuropsychopharmacology ·Steven V. Fox, Anthony L. Gotter, Spencer J. Tye, Susan L. Garson, Alan T. Savitz, Jason M. Uslaner, (unknown), Pamela L. Tannenbaum, Terrence P. McDonald, Robert A. Hodgson, Lihang Yao, Mark R. Bowlby, Scott D. Kuduk, Paul J. Coleman, Richard Hargreaves, Christopher J. Winrow, John J. Renger	33
7	The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold 2013 ·BMC Neuroscience ·Anthony L. Gotter, Christopher J. Winrow, (unknown), Susan L. Garson, Steven V. Fox, (unknown), C. Meacham Harrell, Donghui Cui, Ka Lai Yee, (unknown), Joanne Stevens, Alan T. Savitz, Pamela L. Tannenbaum, Spencer J. Tye, Terrence P. McDonald, (unknown), Scott D. Kuduk, Jason M. Uslaner, Paul J. Coleman, John J. Renger	76
8	High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate 2013 ·Bone ·Antonio Cabal, (unknown), (unknown), (unknown), (unknown), (unknown), Parker D. Mathers, Alan T. Savitz, Boyd B. Scott, Christopher T. Winkelmann, Sherri L. Motzel, (unknown), Richard Hargreaves, Jeffrey L. Evelhoch, Bernard J. Dardzinski, Thomas N. Hangartner, Paul J. McCracken, Le T. Duong, Donald S. Williams	26
9	Pharmacological Validation of Candidate Causal Sleep Genes Identified in an N2 Cross 2011 ·Journal of Neurogenetics ·(unknown), Anthony L. Gotter, Joshua Millstein, Susan L. Garson, (unknown), Steven V. Fox, Alan T. Savitz, He S. Yang, (unknown), (unknown), (unknown), Andrea L. Webber, Martha Hotz Vitaterna, Andrew Kasarskis, Victor N. Uebele, Fred W. Turek, John J. Renger, Christopher J. Winrow	7
10	HR-pQCT based finite element analysis estimates of bone strength at ultra-distal radius in ovariectomized rhesus monkeys demonstrates efficacy of odanacatib and differentiation from Alendronate 2011 ·Bone ·Antonio Cabal, (unknown), (unknown), (unknown), Paul J. McCracken, (unknown), Parker D. Mathers, Alan T. Savitz, (unknown), Donald S. Williams	1
11	Head-to-head comparison of treatment effects of odanacatib to alendronate in the ovariectomized rhesus monkey: A longitudinal multi-modality imaging study 2011 ·Bone ·Donald S. Williams, Paul J. McCracken, (unknown), Mona Purcell, Parker D. Mathers, Alan T. Savitz, (unknown), Antonio Cabal, Bernard J. Dardzinski, Sherri L. Motzel, T. N. Hangartner, Richard Hargreaves, Jeffrey L. Evelhoch, (unknown), Jacquelynn J. Cook	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact